Stanford Study Links Epstein-Barr Virus to Lupus

Groundbreaking research suggests EBV may play a direct role in triggering the autoimmune response in lupus patients.

Feb. 24, 2026 at 9:49pm

Got story updates? Submit your updates here. ›

A new study from Stanford Medicine has revealed a strong connection between the Epstein-Barr virus (EBV) and the development of systemic lupus erythematosus, commonly known as lupus. The research suggests that EBV may hijack and reprogram immune cells, leading to the autoimmune attacks on the body's own tissues that characterize lupus. This discovery offers a potential new avenue for understanding and treating this chronic, debilitating condition.

Why it matters

Lupus is a complex autoimmune disease that affects an estimated 500,000 Americans, disproportionately impacting women. While existing treatments can manage symptoms, a cure remains elusive. This research provides crucial insights into the underlying causes of lupus, potentially paving the way for more effective preventative measures and targeted therapies.

The details

The study, led by researchers at Stanford Medicine, demonstrates how EBV, a virus that infects approximately 80% of the population, can reprogram B cells - a type of white blood cell responsible for producing antibodies. The researchers found that EBV+ B cells in lupus patients express genes like ZEB2 and TBX21 (T-bet) and exhibit heightened antigen-presenting activity, effectively turning them into 'rogue' cells that attack the body's own tissues. Further analysis revealed that the EBV nuclear antigen 2 (EBNA2) binds to regulatory regions of genes crucial for B cell function, driving the autoimmune process.

  • The study was published on February 24, 2026 in the journal Science Translational Medicine.

The players

William Robinson

A professor of immunology and rheumatology at Stanford Medicine and the lead author of the study.

Shady Younis

An instructor in immunology and rheumatology at Stanford Medicine and a co-author of the study.

Lupus Foundation of America

An organization that has previously identified infections, particularly EBV, as a leading environmental suspect in the development of lupus.

Got photos? Submit your photos here. ›

What they’re saying

“We think it applies to 100% of lupus cases. This is the single most impactful finding from our lab.”

— William Robinson, Professor of Immunology and Rheumatology, Stanford Medicine

What’s next

Researchers are now focused on further investigating the specific viral and host factors that contribute to EBV-induced lupus, as well as conducting clinical trials to test potential new therapies. They are also exploring the possibility of a vaccine that could prevent EBV infection or modulate the immune response to the virus, thereby reducing the risk of developing lupus.

The takeaway

This groundbreaking research represents a major advancement in our understanding of lupus, offering a potential pathway toward more effective treatments and, ultimately, a cure for this debilitating autoimmune condition. By unraveling the link between EBV and lupus, scientists have uncovered a promising new avenue for addressing the underlying causes of the disease.